Community Schedule

Enter at least 4 characters

1 results showing for: 'covid-19 vaccine'

  1. Vaccinations
COVID-19 vaccine    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 309.
[Xpharm]
  • Inj 3 mcg SARS-CoV-2 spike protein (mRNA) LP.8.1 per 0.3 ml, 0.48 ml multi-dose vial; infant vaccine, yellow cap
    • Brand Fully subsidised brand. Comirnaty (LP.8.1)
    • Pharmacode2717107
    • Subsidy $0.00
    • Measure / Qty per 10

    Any of the following:

    1. Up to three doses for previously unvaccinated children aged 6 months - 4 years at high risk of severe illness or highly immunocompromised; or

    2. One additional dose with the most current variant-matched vaccine every 6 months for highly immunocompromised children aged 6 months to 4 years; or

    3. One additional dose with the most current variant-matched vaccine every 12 months for children aged 6 months to 4 years old at high risk of severe illness.

  • Inj 3 mcg bretovameran per 0.3 ml, 0.48 ml vial; infant vaccine, yellow cap
    • Brand Fully subsidised brand. Comirnaty Omicron (JN.1)
    • Pharmacode2697378
    • Subsidy $0.00
    • Measure / Qty per 10
    (Comirnaty Omicron (JN.1) Inj 3 mcg bretovameran per 0.3 ml, 0.48 ml vial; infant vaccine, yellow cap to be delisted 01 June 2026)

    Any of the following:

    1. Up to three doses for previously unvaccinated children aged 6 months - 4 years at high risk of severe illness or highly immunocompromised; or

    2. One additional dose with the most current variant-matched vaccine every 6 months for highly immunocompromised children aged 6 months to 4 years; or

    3. One additional dose with the most current variant-matched vaccine every 12 months for children aged 6 months to 4 years old at high risk of severe illness.

  • Inj 10 mcg SARS-CoV-2 spike protein (mRNA) LP.8.1 per 0.3 ml, 0.48 ml single-dose vial; paediatric vaccine, light blue cap
    • Brand Fully subsidised brand. Comirnaty (LP.8.1)
    • Pharmacode2717115
    • Subsidy $0.00
    • Measure / Qty per 10

    Any of the following:

    1. One dose for previously unvaccinated children aged 5–11 years old; or

    2. Up to three doses for immunocompromised children aged 5-11 years old; or

    3. One additional dose with the most current variant-matched vaccine every 6 months for highly immunocompromised children aged 5 to 11 years; or

    4. One additional dose with the most current variant-matched vaccine up to every 12 months for children aged 5 to 11 years old at high risk of severe illness.

  • Inj 10 mcg bretovameran per 0.3 ml, 0.48 ml vial; paediatric vaccine, light blue cap
    • Brand Fully subsidised brand. Comirnaty Omicron (JN.1)
    • Pharmacode2697386
    • Subsidy $0.00
    • Measure / Qty per 10
    (Comirnaty Omicron (JN.1) Inj 10 mcg bretovameran per 0.3 ml, 0.48 ml vial; paediatric vaccine, light blue cap to be delisted 01 June 2026)

    Any of the following:

    1. One dose for previously unvaccinated children aged 5–11 years old; or

    2. Up to three doses for immunocompromised children aged 5-11 years old; or

    3. One additional dose with the most current variant-matched vaccine every 6 months for highly immunocompromised children aged 5 to 11 years; or

    4. One additional dose with the most current variant-matched vaccine up to every 12 months for children aged 5 to 11 years old at high risk of severe illness.

  • Inj 30 mcg SARS-CoV-2 spike protein (mRNA) LP.8.1 per 0.3 ml, pre-filled syringe; adult dose
    • Brand Fully subsidised brand. Comirnaty (LP.8.1)
    • Pharmacode2717123
    • Subsidy $0.00
    • Measure / Qty per 10

    Any of the following:

    1. One dose for previously unvaccinated people aged 12-15 years and over 30 years old; or

    2. Two doses for previously unvaccinated people aged 16-29 years old; or

    3. Up to three doses for previously unvaccinated immunocompromised people from 12 years old; or

    4. Up to four doses for people at risk of severe illness aged from 12-29 years; or

    5. One additional dose with the most current variant-matched vaccine every 6 months, any of the following criteria:

      1. Previously vaccinated people aged 30 years and over; or

      2. Previously vaccinated immunocompromised people from 12 years; or

      3. Previously vaccinated people at high-risk from 12 years.

  • Inj 30 mcg bretovameran per 0.3 ml, 0.48 ml vial; adult vaccine, light grey cap
    • Brand Fully subsidised brand. Comirnaty Omicron (JN.1)
    • Pharmacode2697394
    • Subsidy $0.00
    • Measure / Qty per 10
    (Comirnaty Omicron (JN.1) Inj 30 mcg bretovameran per 0.3 ml, 0.48 ml vial; adult vaccine, light grey cap to be delisted 01 June 2026)

    Any of the following:

    1. One dose for previously unvaccinated people aged 12-15 years and over 30 years old; or

    2. Two doses for previously unvaccinated people aged 16-29 years old; or

    3. Up to three doses for previously unvaccinated immunocompromised people from 12 years old; or

    4. Up to four doses for people at risk of severe illness aged from 12-29 years; or

    5. One additional dose with the most current variant-matched vaccine every 6 months, any of the following criteria:

      1. Previously vaccinated people aged 30 years and over; or

      2. Previously vaccinated immunocompromised people from 12 years; or

      3. Previously vaccinated people at high-risk from 12 years.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply



Email enquiry@pharmac.govt.nz to provide feedback: compliments, suggestions and complaints.